Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CONMED Corporation | CNMD | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 75.23 | 04:05:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 75.23 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 73.875 - 138.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 75.23 | USD |
CONMED Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.12B | 30.78M | - | 1.24B | 64.46M | 2.09 | 48.43 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CONMED News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 78.63 | 80.65 | 73.875 | 76.60 | 419,013 | -3.40 | -4.32% |
| 1 Month | 76.21 | 81.22 | 73.875 | 77.14 | 445,252 | -0.98 | -1.29% |
| 3 Months | 100.82 | 101.71 | 73.875 | 82.86 | 574,087 | -25.59 | -25.38% |
| 6 Months | 94.64 | 117.27 | 73.875 | 92.29 | 476,248 | -19.41 | -20.51% |
| 1 Year | 110.36 | 138.47 | 73.875 | 103.50 | 418,403 | -35.13 | -31.83% |
| 3 Years | 132.53 | 159.11 | 71.09 | 108.57 | 357,249 | -57.30 | -43.24% |
| 5 Years | 100.14 | 159.11 | 37.66 | 102.38 | 351,380 | -24.91 | -24.88% |
CONMED Description
| Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%. |
